Gain Therapeutics (GANX) Assets (2020 - 2026)
Gain Therapeutics' Assets was $15.42 million in Q2 2026, up 56.8% from $9.83 million a year earlier but down 17.7% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Assets at Gain Therapeutics came in at $22.82 million, up 88.2% from FY2024.
- Assets shows a five-year compound annual growth rate of 18.9% (FY2020 to FY2025).
- In earlier years, Assets was $12.12 million in FY2024 (-34.9%), $18.61 million in FY2023 (-22.8%), $24.1 million in FY2022 (-38.2%) and $38.99 million in FY2021 (+305.9%).
- Quarterly Assets has moved between $9.83 million (Q2 2025) and $42.56 million (Q3 2021) over five years.
- Compared with a year earlier, Assets has increased for three straight quarters, with growth averaging 10.1% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q4 2021 (growth of 305.9%); the worst was Q3 2023 (a decline of 50.2%).
- Per Business Quant data, GANX's Assets in the three quarters before Q2 2026 was $18.74 million (Q1 2026), $22.82 million (Q4 2025) and $10.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Gain Therapeutics | 49.78 Mn | -9.50 Mn | - | 15.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.42 Mn |
| Mar 31, 2026 | 18.74 Mn |
| Dec 31, 2025 | 22.82 Mn |
| Sep 30, 2025 | 10.97 Mn |
| Jun 30, 2025 | 9.83 Mn |
| Mar 31, 2025 | 11.62 Mn |
| Dec 31, 2024 | 12.12 Mn |
| Sep 30, 2024 | 14.37 Mn |
| Jun 30, 2024 | 19.20 Mn |
| Mar 31, 2024 | 14.58 Mn |
| Dec 31, 2023 | 18.61 Mn |
| Sep 30, 2023 | 14.10 Mn |
| Jun 30, 2023 | 18.26 Mn |
| Mar 31, 2023 | 21.32 Mn |
| Dec 31, 2022 | 24.10 Mn |
| Sep 30, 2022 | 28.33 Mn |
| Jun 30, 2022 | 31.89 Mn |
| Mar 31, 2022 | 37.60 Mn |
| Dec 31, 2021 | 38.99 Mn |
| Sep 30, 2021 | 42.56 Mn |
API Access
Gain Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();